HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seroprotection after hepatitis B vaccination in children aged 1 to 15 years in central province of Iran, Semnan.

AbstractINTRODUCTION:
There are controversies over the long-term persistence of post vaccination immunity to hepatitis B and the need for booster doses of the vaccine. The aim of this study was to verify antibody levels of antibody against hepatitis B virus surface antigen (anti-HBs) in children aged 1 to 15 years who received vaccination against hepatitis B in the central province of Iran, Semnan.
MATERIALS AND METHODS:
We performed a seroepidemiological survey (n = 210) of anti-HBs in 2011 in the central province of Iran, Semnan using enzyme-linked immunosorbent assay (ELISA). The levels of anti-HBs < 10 mIU/mL were considered to be negative and samples showing an anti-HBs titer ≥ 10 mIU/mL was considered protective.
RESULTS:
Protective antibody levels were detected in 88% of the children less than 5 year after vaccination, decreased to 78% between 5 to 10 years after vaccination, and further declined to 74% in 10 years after vaccination, respectively.
CONCLUSION:
The vaccination program has been proven effective in Semnan and immunological protection against hepatitis B infection was found in the majority of children even more than 10 years after being vaccinated.
AuthorsM Rezaei, S Nooripoor, R Ghorbani, F Ramezanshams, S Mamishi, S Mahmoudi
JournalJournal of preventive medicine and hygiene (J Prev Med Hyg) Vol. 55 Issue 1 Pg. 1-3 (Mar 2014) ISSN: 1121-2233 [Print] Italy
PMID25916024 (Publication Type: Journal Article)
Chemical References
  • Hepatitis B Antibodies
  • Hepatitis B Surface Antigens
  • Hepatitis B Vaccines
Topics
  • Adolescent
  • Child
  • Child, Preschool
  • Cross-Sectional Studies
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Hepatitis B (immunology, prevention & control)
  • Hepatitis B Antibodies (immunology)
  • Hepatitis B Surface Antigens (immunology)
  • Hepatitis B Vaccines (immunology, therapeutic use)
  • Hepatitis B virus (immunology)
  • Humans
  • Infant
  • Iran
  • Male
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: